Literature DB >> 24315895

Percutaneous interventional therapies for the treatment of patients with severe pulmonary hypertension.

Paul Bhamra-Ariza1, Anne M Keogh2, David W M Muller3.   

Abstract

Despite improvements in medical therapy, the overall prognosis of patients with severe pulmonary arterial hypertension remains poor. Heart-lung transplantation or bilateral lung transplantation is the final pathway for a minority. This paper describes both established and novel percutaneous interventional techniques that may palliate or bridge pulmonary hypertension patients to transplantation.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  intervention; percutaneous; pulmonary hypertension

Mesh：

Year:  2013        PMID： 24315895     DOI： 10.1016/j.jacc.2013.11.022

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


  8 in total

1.  Adaptive right ventricular performance in response to acutely increased afterload in a lamb model of congenital heart disease: evidence for enhanced Anrep effect.

Authors:  Rebecca C Johnson; Sanjeev A Datar; Peter E Oishi; Stephen Bennett; Jun Maki; Christine Sun; Michael Johengen; Youping He; Gary W Raff; Andrew N Redington; Jeffrey R Fineman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

Review 2.  Pulmonary hypertension: diagnosis, imaging techniques, and novel therapies.

Authors:  Alan B Goldberg; Wojciech Mazur; Dinesh K Kalra
Journal:  Cardiovasc Diagn Ther       Date:  2017-08

3.  The clinical value of assessing right ventricular diastolic function after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Hidenori Moriyama; Mitsushige Murata; Toshimitsu Tsugu; Takashi Kawakami; Masaharu Kataoka; Takahiro Hiraide; Mai Kimura; Sarasa Isobe; Jin Endo; Takashi Kohno; Yuji Itabashi; Keiichi Fukuda
Journal:  Int J Cardiovasc Imaging       Date:  2017-12-30       Impact factor: 2.357

Review 4.  Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.

Authors:  Bradley A Maron; Jane A Leopold
Journal:  Circulation       Date:  2015-06-09       Impact factor: 29.690

5.  Catheter-based therapies for patients with medication-refractory pulmonary arterial hypertension.

Authors:  Jane A Leopold
Journal:  Circ Cardiovasc Interv       Date:  2015-11       Impact factor: 6.546

6.  Comparison of the efficacy of four endobronchial ablation techniques in dogs.

Authors:  Linrong Tong; Koudong Zhang; Haidong Huang; Wei Zhang; Xingxing Zhang; Qin Wang; Qiang Li; Chong Bai
Journal:  Exp Ther Med       Date:  2016-12-01       Impact factor: 2.447

7.  Graded balloon atrial septostomy for palliation of congenital pulmonary hypertension in a dog: A case report.

Authors:  Justin Allen; Nathan Peterson; Kirstie Barrett; Anthony Llamas
Journal:  J Vet Intern Med       Date:  2019-11-26       Impact factor: 3.333

Review 8.  Pathological Mechanisms and Potential Therapeutic Targets of Pulmonary Arterial Hypertension: A Review.

Authors:  Ying Xiao; Pei-Pei Chen; Rui-Lin Zhou; Yang Zhang; Zhuang Tian; Shu-Yang Zhang
Journal:  Aging Dis       Date:  2020-12-01       Impact factor: 6.745
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.